- Home
- HUMA vs NBP Comparison
HUMA vs NBP Comparison
Compare HUMA & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMA
- NBP
- Stock Information
- Founded
- HUMA 2004
- NBP 2014
- Country
- HUMA United States
- NBP United States
- Employees
- HUMA N/A
- NBP N/A
- Industry
- HUMA Biotechnology: Pharmaceutical Preparations
- NBP Biotechnology: Pharmaceutical Preparations
- Sector
- HUMA Health Care
- NBP Health Care
- Exchange
- HUMA Nasdaq
- NBP Nasdaq
- Market Cap
- HUMA 324.0M
- NBP 370.8M
- IPO Year
- HUMA N/A
- NBP 2020
- Fundamental
- Price
- HUMA $1.33
- NBP $4.00
- Analyst Decision
- HUMA Strong Buy
- NBP
- Analyst Count
- HUMA 8
- NBP 0
- Target Price
- HUMA $10.13
- NBP N/A
- AVG Volume (30 Days)
- HUMA 5.0M
- NBP 505.5K
- Earning Date
- HUMA 11-12-2025
- NBP 11-14-2025
- Dividend Yield
- HUMA N/A
- NBP N/A
- EPS Growth
- HUMA N/A
- NBP N/A
- EPS
- HUMA N/A
- NBP N/A
- Revenue
- HUMA $1,571,000.00
- NBP N/A
- Revenue This Year
- HUMA N/A
- NBP N/A
- Revenue Next Year
- HUMA $1,468.13
- NBP N/A
- P/E Ratio
- HUMA N/A
- NBP N/A
- Revenue Growth
- HUMA N/A
- NBP N/A
- 52 Week Low
- HUMA $1.09
- NBP $0.60
- 52 Week High
- HUMA $6.77
- NBP $6.79
- Technical
- Relative Strength Index (RSI)
- HUMA 46.13
- NBP N/A
- Support Level
- HUMA $1.09
- NBP N/A
- Resistance Level
- HUMA $1.26
- NBP N/A
- Average True Range (ATR)
- HUMA 0.11
- NBP 0.00
- MACD
- HUMA 0.02
- NBP 0.00
- Stochastic Oscillator
- HUMA 69.12
- NBP 0.00
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.